For: | Sheng W, Ji G, Zhang L. Management of non-alcoholic fatty liver disease patients with sleep apnea syndrome. World J Gastroenterol 2022; 28(43): 6099-6108 [PMID: 36483151 DOI: 10.3748/wjg.v28.i43.6099] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v28/i43/6099.htm |
Number | Citing Articles |
1 |
Mingyu Lai, Xinhua Ye. Correlation analysis of LXR and its target genes COX2 and CETP with the severity of OSAHS in obese young rats. Sleep and Breathing 2025; 29(1) doi: 10.1007/s11325-024-03208-9
|
2 |
Lulu Gan, Anni Dai, Yan He, Shijie Liu, Qing Ni, Yang Hu, Qian Liu, Li Yang. Exosomal LncRNA MALAT1 Derived from Hepatocytes in Nonalcoholic Fatty Liver Disease Regulates the miR-579-3p/Keap1/Nrf2 Pathway to Exacerbate Obstructive Sleep Apnea Syndrome. Molecular Biotechnology 2025; doi: 10.1007/s12033-025-01499-1
|
3 |
Ping Wang, Shuli Liu, Ling Min Kong, Nannan Qi. Causal Relationship Between Childhood Obesity and Sleep Apnea Syndrome: Bidirectional Two-Sample Mendelian Randomization Analysis. Nature and Science of Sleep 2024; : 1713 doi: 10.2147/NSS.S477435
|
4 |
Chantal Jacqueline Córdova-Gallardo, Andres Manuel Vargas-Beltran, Mariana M. Ramírez Mejía, Nahum Méndez-Sánchez. Metabolic Dysfunction-Associated Steatotic Liver Disease. 2024; : 87 doi: 10.1007/978-981-97-9519-2_7
|